In Brief
The kidney is the main target organ in systemic C. albicans infection. Domínguez-André s et al. now show that effective defense against systemic candidiasis relies on type I interferondependent IL-15 production by spleen inflammatory monocytes, which drives splenic NK cell activation and GM-CSF release that in turn boost the candidacidal potential of kidney neutrophils.
INTRODUCTION
Candida species are the most common cause of fungal infection in immunocompromised patients. Systemic candidiasis can lead to severe life-threatening invasive disease in patients receiving immunosuppressive therapy for autoimmune diseases or organ transplantation, and in those with neoplastic disease, AIDS, or undergoing major surgery. The incidence of invasive candidiasis has risen dramatically over the past decades and this disease is associated with a high mortality rate, exceeding 40% (Kullberg and Arendrup, 2015) . Current therapies for invasive candidiasis, based on the use of antifungal drugs, have low efficacy in immunocompromised patients, and the emergence of resistance to antifungal agents is becoming a major concern (Kanafani and Perfect, 2008) . A growing body of evidence supports the notion that the design of effective therapies against fungal infections requires the development of immunotherapeutic strategies, which could be combined with antifungal chemotherapy. However, despite intense research efforts, the development of efficient antifungal immunotherapies has fallen behind in part due to an insufficient understanding of the host-pathogen interactions involved and the mechanisms underlying the induction of protective immunity or immune escape during fungal infections.
Defense against fungal infections relies to a great extent on the activation of neutrophils, a process sequentially controlled first by the innate immune response and subsequently by the adaptive branch of antifungal immunity (Netea et al., 2015) . Whereas neutrophil recruitment and activation during antifungal adaptive immunity has been analyzed in-depth (Herná ndez-Santos and Gaffen, 2012), few studies have attempted to unravel the innate immune mechanisms that boost the candidacidal activity of neutrophils during the early phases of fungal infection. Interestingly, a recent report demonstrated that NK cells, generally associated with anti-viral, anti-bacterial, or anti-tumoral immunity, play a crucial role in the early defense against systemic Candida albicans infection in mice through the production of the cytokine GM-CSF, which is required for the activation of neutrophils in this infection model (B€ ar et al., 2014) . Whereas this report represents a groundbreaking contribution to the field, it also led to several yet unsolved questions related to NK cell and neutrophil activation during the early anti-Candida innate immune response. Which are the cells and mediators responsible for this early NK cell activation? Where do NK cell-activating cells encounter and respond to infection? Where are NK cells and neutrophils activated during the early phases of systemic candidiasis? In this regard, by using a model of inducible diphtheriatoxin-mediated monocyte depletion Ngo et al., have reported that inflammatory Ly6C high monocytes are critical during the first 48 hr after C. albicans infection for the induction of a protective response (Ngo et al., 2014) . In line with this finding, recent reports have also highlighted the functional relevance of inflammatory Ly6C high monocytes in the induction of the early phases of innate immunity against microbial infections (Soudja et al., 2012; Xiong et al., 2016) . These studies prompted us to explore the role of inflammatory Ly6C high monocytes in the activation of the NK cell-neutrophil axis during the early innate immune response against C. albicans, using a murine model of systemic candidiasis in which the kidney is the main target organ (Lionakis et al., 2011) . We found that during C. albicans infection, the production of IL-15 by spleen inflammatory Ly6C high monocytes was needed for an efficient activation and production of GM-CSF by spleen NK cells, which in turn was required to boost the Candida killing potential of neutrophils. IL-15 production by Ly6C high monocytes was strictly dependent on type I interferon (IFN) production, which had a crucial role in defense against C. albicans infection (del Fresno et al., 2013) . Thus, IL-15 plays a critical function in the activation of the NK cell-neutrophil axis during systemic candidiasis and defense against Candida relies on the induction of spleen-kidney cooperative innate immunity wherein the production of IL-15 and activation of NK cells in the spleen enables an efficient GM-CSF-dependent activation of neutrophils and the clearance of Candida in the kidney. These findings provide a basis for the design of IL-15-based immunotherapeutic strategies for the treatment of invasive candidiasis affecting immunocompromised patients.
RESULTS
Characterization of Kidney and Spleen DC, Monocyte, and Macrophage Subsets during Systemic C. albicans Infection We first performed, in non-infected C57BL/6 mice, a detailed analysis of the different subsets of dendritic cells (DCs), monocytes and macrophages (MØs) present in the kidney, the main target organ after systemic C. albicans infection. Kidney cell suspensions obtained after enzymatic digestion were analyzed by 7-color flow cytometry. After gating on CD45 + cells, and exclusion of cells expressing CD90 (T cells), CD19 (B cells), CD49b (NK cells), Siglec-F (eosinophils), or Ly6G (neutrophils), a sequential gating strategy based on the differential expression of CD11b, CD64, Ly6C, MHCII, and CD11c ( Figure S1 ), allowed for the characterization of kidney-resident MØs, Ly6C low and Ly6C high monocytes, monocyte-derived DCs (moDCs), and conventional DCs (cDCs). In addition, CD64 int , CD11b high immature moDCs (i-moDCs), co-expressing Ly6C and MHCII, can be defined in non-infected mice, although this population was more prominent 24 hr after C. albicans infection ( Figure 1A ). NK cells and neutrophils were identified as CD49b + CD3 À cells, and Ly6G + cells, respectively ( Figure S1 ).
We next analyzed the kinetics of these cell subsets in the kidney during the first 48 hr after infection ( Figures 1A and 1B) , since innate immunity mechanisms against C. albicans are triggered during the first hours of infection (Netea et al., 2008) . During the first 24 hr post-infection large numbers of Ly6C high monocytes and neutrophils were recruited to the kidney. Along the next 24 hr the recruitment of Ly6C high monocytes and neutrophils continued and was accompanied by the recruitment of large numbers of Ly6C low monocytes. As a consequence, the number of Ly6C low , Ly6C high monocytes, and neutrophils increased around 50-, 100-, and 150-fold, respectively, during the first 48 hr. The number of NK cells recruited to the kidney also increased substantially during the first 24 hr post-infection. In contrast, during the first 48 hr the number of resident macrophages (res-MØs) remained unchanged, and cDCs underwent just a moderate increase in number. At 48 hr the number of moDCs was more than 10-fold lower than the number of Ly6C high monocytes ( Figure 1B) , suggesting that the differentiation of Ly6C high monocytes into moDCs was limited by the infection process. This hypothesis was supported by the low number of i-moDCs at 48 hr post-infection, and by the fact that the decreased expression of Ly6C in Ly6C high monocytes was not concomitant with the increased expression of MHCII ( Figure 1A ). Since the spleen fulfills an important function against systemic infections and is transiently infected by C. albicans during the first hours after infection (Lionakis et al., 2011) , we analyzed the kinetics of recruitment of DCs, monocytes, and MØs to the spleen during the first 48 hr after C. albicans infection. There was a significant increase in the number of Ly6C high monocytes and neutrophils (around 3-and 10-fold respectively at 48 hr) in the spleen, but not of Ly6C low monocytes (Figures S1, 2A and 2B) . Although the increase in the number of monocytes and neutrophils was lower in the spleen than in the kidney, it is important to note that the size of these cell populations was significantly higher in the spleen both at 24 and 48 hr post-infection (Figures 1B and 2B) . Consequently, during the first hours of infection, Ly6C high monocytes and neutrophils were rapidly recruited to the kidney and spleen, the latter harboring a substantially higher number of both cell types. In contrast, the number of spleen NK cells remained unchanged during the first 24 hr, but underwent a significant reduction from 24 to 48 hr. Importantly, the size of the NK cell population was around 100-fold higher in the spleen than in the kidney ( Figures 1B and 2B ).
CCR2 Deficiency Increases Susceptibility to Systemic C. albicans Infection
To explore the contribution of monocytes to the early innate immune response against Candida, we initially analyzed the kinetics of DCs, monocytes, MØs, NK cells, and neutrophils in the kidney and spleen after C. albicans infection in mice deficient for CCR2 (Ccr2 À/À mice), a chemokine receptor controlling the egress of Ly6C high monocytes from the bone marrow, and thus their recruitment to inflammatory foci (Shi and Pamer, 2011) . The number of res-MØs, Ly6C low monocytes, and cDCs were not significantly affected in the kidney of Ccr2 À/À mice ( Figure 1C and 1D moDCs, and neutrophils in the spleen at 24 and 48 hr post infection and led to a significant reduction in the number of cDCs ( Figure 2C and 2D). We next analyzed the impact on defense against C. albicans, of the reduction primarily in the number of Ly6C high monocytes, and additionally in moDCs, cDCs and neutrophils, occurring in the kidney and spleen of Ccr2 À/À mice during the first 48 hr.
Ccr2
À/À mice harbored a significantly higher renal fungal load at 24 hr post-infection than control mice, and this difference in fungal load was more prominent at 48 hr ( Figure 3A ). Correspondingly, the size of renal leukocytic infiltrates and growth of Candida hyphae, as assessed in histological sections, was significantly higher in Ccr2 À/À mice ( Figure S2 ), whereas the survival was significantly higher in WT mice ( Figure 3B ). Analysis of the C. albicans killing ability of blood neutrophils revealed that whereas in control mice a significant increase in neutrophil killing potential occurred during the first 48 hr, in Ccr2 À/À mice the killing ability of neutrophils was not significantly increased during infection ( Figure 3C ). Consequently, after infection, blood neutrophils from WT mice acquired a higher candidacidal potential than their Ccr2 À/À counterparts. In line with these data, neutrophils isolated from the kidney of control mice 48 hr post infection had a significantly higher C. albicans killing ability than those isolated from Ccr2 À/À mice ( Figure 3C ), and displayed a higher amount of mRNA transcripts encoding the enzyme inducible nitric oxide synthase (iNOS; Figure 3D ), which catalyzes the production of nitric oxide, a strong candidacidal molecule (Naglik, 2014 Figure S1 ) before and after infection in WT (A) and Ccr2 À/À mice (C) .
(B and D) Absolute cell number per mouse of the indicated kidney cell subsets after infection, in WT (B) and Ccr2 À/À mice (D). Data are expressed as mean ± SEM of four mice per condition. *p < 0.05; **p < 0.01; ***p < 0.001; unpaired t test. Red asterisks indicate the statistical significance of the differences between WT and Ccr2 À/À mice. Similar results were obtained in at least three independent experiments. See also Figure S1 .
( Figure 3D ). Therefore, during the first 48 hr post-infection, the higher Candida killing ability of neutrophils from WT mice, as compared to that of Ccr2 À/À mice, correlated with a lower kidney fungal burden and a prolonged survival. As pointed out above, GM-CSF production by NK cells is crucial to boost the candidacidal potential of neutrophils (B€ ar et al., 2014) . We therefore sought to assess whether in Ccr2 À/À mice, the decreased Candida killing ability of neutrophils reflected the production of lower amounts of GM-CSF by NK cells.
ELISA analysis of GM-CSF levels in blood serum showed that Ccr2 À/À mice produced lower amounts of GM-CSF than their WT counterparts both at 24 and at 48 hr post-infection (Figure 3E) . In addition, these experiments revealed that higher serum GM-CSF levels were detectable at 24 hr than at 48 hr.
In line with these findings, the expression of GM-CSF-specific mRNA by MACS-sorted CD45 À/À mice revealed no detectable IFN-g production and significantly reduced granzyme B production, indicating that NK cell activation was defective after C. albicans infection of Ccr2 À/À mice ( Figure 3H ). In addition, kidney NK cells were poorly activated after C. albicans infection of either WT or Ccr2 À/À mice, indicating that the ability of these cells to produce GM-CSF during C. albicans infection was limited (Figure S3) . Therefore, it can be hypothesized that in Ccr2
mice, poor NK cell activation led to reduced GM-CSF production, which in turn compromised the candidacidal ability of neutrophils and resulted in a higher kidney fungal load and a lower survival. Figure 4A ) and CD45 + kidney infiltrating leukocytes ( Figure 4B ). No differences were observed between the two genotypes for all the cytokines analyzed with the exception of IL-15, which was markedly increased at 24 hr both in the spleen and kidney in WT, but not in Ccr2 À/À mice.
These results suggest that at 24 hr post-infection, in Ccr2
mice the production of IL-15, a key cytokine for the development and function of NK cells (Di Santo, 2006) , was compromised most likely due to a defective recruitment and/or development of a CCR2-dependent cell population, in the spleen and/or the kidney.
To confirm this hypothesis, we assessed which were the main IL-15 producer cells in the spleen and kidney of C. albicans-infected WT mice by analyzing, by flow cytometry, the expression of IL-15Ra, the IL-15 trans-presenting receptor that is coexpressed with IL-15 (Mortier et al., 2008) . Our data revealed that, in the spleen, Ly6C high monocytes were the main cell population expressing IL-15Ra ( Figures 4C and 4D ). At 24 hr, around 80% Ly6C high monocytes expressed IL-15Ra, which was dramatically reduced by 48 hr post-infection. DCs (including moDCs and cDCs) and neutrophils followed similar kinetics, although only up to 10% and 5% of these cell populations, respectively, expressed IL-15Ra at 24 hr post-infection. IL15Ra + cells were not detectable among splenic resident MØs or lymphoid cells. Consequently, Ly6C high monocytes represented around 80% of all spleen IL-15Ra + cells, indicating that they constituted the main splenic IL-15-producing population. The kinetics of IL-15Ra expression was similar in the kidney of C. albicans infected mice, but only around 30% Ly6C high monocytes expressed IL-15Ra at 24 hr ( Figures 4E and 4F ). Up to 20% kidney-resident MØs were positive for IL-15Ra, that was barely detectable among kidney DCs or neutrophils. Thus, Ly6C high monocytes also constituted the main IL-15 producing cell cells were far less efficient in the kidney than in the spleen. It is important to note that the fungal load was maintained at low levels in the spleen whereas it increased progressively in the kidney along this period ( Figure S4 ). It can be hypothesized that the ability of the spleen to control the early phases of infection favored the induction of IL-15 production and subsequent NK cell activation, whereas the high level of infection harbored by the kidney, reflecting its low capacity to clear Candida during the first hours post-infection, restrained these processes.
NK Cell Activation during C. Figure 5B), supporting that IL-15 production by Ly6C high monocytes was required for spleen NK cell activation in response to C. albicans infection in vivo. Interestingly, GM-CSF and IFN-g production in response to LPS was unaffected by IL-15 deficiency. Of note, neither GM-CSF nor IFN-g production was detected after culture of NK cells or Ly6C high monocytes alone.
To validate these results from in vitro experiments, we first explored the IL-15 requirement for an efficient NK cell activation during in vivo C. albicans infection. To this end, C57BL/6 mice were treated with an anti-IL-15Ra/IL-15 blocking mAb concomitantly with the infection with C. albicans, and NK cell activation was analyzed at 24 hr post-infection. Our results revealed that in mice treated with anti-IL-15/IL-15a mAb the production of IFN-g by spleen NK cells was barely detectable and, correspondingly, the levels of GM-CSF in serum and Candida killing potential of neutrophils were markedly reduced, leading to an increased kidney fungal load ( Figures 5C and 5D ), indicating that IL-15 is a key mediator of NK cell activation during C. albicans infection. In this context, since, as mentioned above, IL-15 is required for NK cell development (Di Santo, 2006) , Il15 À/À mice, compared to their WT counterparts, had, as expected, markedly lower GM-CSF levels in serum, spleen, and kidney, paralleled with a significantly reduced iNOS expression and Candida killing ability of neutrophils, that led to a higher kidney fungal burden and reduced survival ( Figure S5 ). In contrast, monocyte candidacidal potential after Candida infection was not affected by IL-15 deficiency ( Figure S5F ), revealing that IL-15 had a key role in boosting the Candida killing potential of neutrophils through NK cell activa- Figures 5G and 5H ). Taken together, these results strongly suport that during C. albicans infection, the activation of NK cells, allowing an efficient GM-CSF dependent Candida killing by neutrophils, was dependent on the production of IL-15 by Ly6C high monocytes. In addition, the analysis of the expression of CD122 (IL-2/15Rb, that forms, together with the common cytokine-receptor gamma-chain, the IL-15 receptor) confirmed that CD122 was expressed by NK cells but not, at detectable levels, by neutrophils ( Figure S6 ), supporting that during C. albicans infection IL-15 had not a direct effect on the fungicidal potential of neutrophils. Therefore, our data demonstrate that Ly6C high monocytes are crucial effector cells for anti-Candida innate immunity, and reveal a new function for IL-15 by demonstrating that this cytokine plays a major role in the activation of the NK cell-neutrophil axis during C. albicans infection.
IL-15 Production during C. albicans Infection Is Controlled by Type I IFN Signaling
Previous data from our group have demonstrated that dectin-1-Syk-IRF5-dependent type I IFN production is crucial for defense against C. albicans infection (del Fresno et al., 2013) . On the other hand, the production of IL-15 in response to TLR ligands was reported to depend on signaling though the type I IFN receptor (IFNAR) (Lucas et al., 2007) . These studies led us to hypothesize that IFNAR signaling might also be required for IL-15 production during C. albicans infection, and consequently that type I IFN production has an essential role in the control of NK cell-neutrophil activation during systemic candidiasis. To address this issue, we first sought to explore whether IL-15 production by Ly6C high monocytes after C. (D) Analysis of IFN-g production by spleen NK cells by flow cytometry after intracellular staining, GM-CSF levels in blood serum by ELISA, candidacidal activity of blood neutrophils, and kidney fungal burden was performed, at the indicated times, in C57BL/6 mice treated with an anti-IL-15Ra/IL-15 blocking antibody, or an isotype control antibody, following the protocol described in (C) .
(E) Protocol of recombinant IL-15 treatment and C. albicans infection in WT and Ccr2 À/À mice.
(F) Analysis of IFN-g production by spleen NK cells by flow cytometry after intracellular staining, GM-CSF levels in blood serum by ELISA, candidacidal activity of blood neutrophils and kidney fungal burden was performed, at the indicated times, in WT and Ccr2 À/À mice treated with IL-15 or PBS, following the protocol described in (E).
(G) Protocol of WT or Il15 À/À monocyte transfer and C. albicans infection in Ccr2 À/À mice.
(H) Analysis of IFN-g production by spleen NK cells by flow cytometry after intracellular staining, GM-CSF levels in blood serum by ELISA, candidacidal activity of blood neutrophils and kidney fungal burden was performed, at the indicated times, in Ccr2 À/À mice after transfer of WT or Il15 À/À monocytes and C. albicans infection, following the protocol described in (G). Data are expressed as mean ± SEM of four to eight mice per condition. *p < 0.05; **p < 0.01; ***p < 0.001; unpaired t test. Similar results were obtained in at least two independent experiments. ELISA data for unstimulated cells were below the detection level of the ELISA kits used in this study (63 pg/ml for GM-CSF and 31.6 pg/ml for IFN-g). i.v. intravenous; n.d., not detectable. See also Figure S6 . (H) Analysis of IFN-g production by spleen NK cells by flow cytometry after intracellular staining, GM-CSF levels in blood serum by ELISA, candidacidal activity of blood neutrophils, and kidney fungal burden was performed, at the indicated times, in Ccr2 À/À mice after transfer of WT or Ifnar1 À/À monocytes and C. albicans infection, following the protocol described in (F). Data are expressed as mean ± SEM of four to six mice per condition. *p < 0.05; **p < 0.01; ***p < 0.001; unpaired t test. Similar results were obtained in at least two independent experiments. ELISA data for non-infected mice were below the detection level of the ELISA kit used (63 pg/ml). n.i., non-infected; n.d., not detectable. See also Figure S7 .
( Figure S7 ). Interestingly, no induction of IL-15 was detectable in CD11b + spleen cells or CD45 + kidney infiltrating leukocytes after
C. albicans infection of Ifnar1
À/À mice ( Figure 6B ). Flow cytometry analysis of splenic resident MØs, Ly6C high monocytes, DCs and neutrophils confirmed that IL-15Ra was not detectable at the protein level in Ifnar1 À/À mice ( Figure 6C ). In line with these data, the production of GM-CSF, induction of iNOS in kidney infiltrating leukocytes and candidacidal potential of neutrophils were strongly inhibited in C. albicans-infected Ifnar1 À/À mice ( Figures 6D-6F ). Globally, these findings demonstrate that during C. albicans infection, IL-15 production by inflammatory monocytes is strictly dependent on IFNAR signaling. Interestingly, the transfer of Ly6C high monocytes from WT, but not from Ifnar1 À/À mice, rescued the defective NK cell activation, GM-CSF production and neutrophil Candida killing ability of Ccr2 À/À mice, leading to a reduction of the kidney fungal burden to WT mouse values ( Figures 6G and 6H ). These data confirmed that during Candida infection, IFNAR signaling in Ly6C high monocytes is required for an effective activation of the NK cellneutrophil axis and thus protection against systemic candidiasis. Globally, these experiments further reinforce the concept that type I IFN production is crucial for defense against systemic candidiasis.
Spleen-Kidney Cooperation during Systemic C. albicans Infection
In mice, the kidney is the main target organ after systemic candidiasis, and therefore clearance of Candida requires that neutrophils recruited to the kidney perform efficiently their candidacidal function (Netea et al., 2015) . On the other hand, our results reveal that defense against C. albicans requires the release of IL-15 by spleen inflammatory monocytes that triggers the production, primarily by spleen NK cells, of GM-CSF, reported to be required to boost the Candida killing potential of neutrophils (B€ ar et al., 2014) . Therefore, our results support that innate immunity against C. albicans infection relies on the induction of cooperative defense mechanisms involving the spleen and kidney. It can be hypothesized that the production of IL-15 by spleen inflammatory monocytes, and subsequent activation of large numbers of spleen NK cells followed by the production of high levels of GM-CSF, would be required for an efficient induction of the candidacidal ability of neutrophils involved in Candida clearance in the kidney.
To assess the contribution of the spleen to the induction of anti-Candida innate immunity after systemic C. albicans infection, we performed experiments in mice splenectomized 4 weeks before infection ( Figure 7A) . Interestingly, at 24 hr post-infection, a marked increase in serum and kidney GM-CSF levels, comparable to that observed in C57BL/6 mice (see Figure 3E ), was detectable in sham-operated mice, but not in splenectomized mice ( Figure 7B ). Of note, low serum GM-CSF levels were detectable both in non-infected sham-operated mice and noninfected splenectomized mice, probably due to the surgical procedure. Accordingly, in C. albicans-infected splenectomized mice, the low iNOS mRNA expression detected in MACS-sorted CD45 + kidney infiltrating leukocytes was paralleled by a defective induction above the basal values of non-infected mice, of the candidacidal potential of blood neutrophils (Figures 7C and  7D ). As expected, the kidney fungal burden was significantly higher in splenectomized mice ( Figure 7E) , and consequently the survival of splenectomized mice was severely compromised ( Figure 7F ). These data demonstrate that the early innate immune response against C. albicans occurring in the spleen plays a crucial role in the induction of the immune mechanisms responsible to Candida clearance in the kidney, and thus in defense against systemic candidiasis. On the other hand, the fact that the reduction in GM-CSF production and neutrophil Candida killing ability, as well as the increase in kidney fungal load were similar when Ccr2 À/À mice were compared to WT mice, and when splenectomized mice were compared to the sham-operated mice, supports that the main contribution of the spleen to innate immunity against systemic candidiasis during the first phases of infection, was to drive the activation and GM-CSF production by NK cells and subsequently to boost the candidacidal potential of neutrophils, through the production of IL-15 by spleen inflammatory Ly6C high monocytes.
DISCUSSION
The cytokine IL-15 is known to be crucial for NK cell development (Di Santo, 2006) , and for NK cell activation in defense against tumors and parasitic and microbial infections (Perera et al., 2012) . Our studies have revealed a role for IL-15 as a critical mediator in defense against systemic candidiasis. We found that IL-15 is crucial for the activation and GM-CSF production by NK cells, which is required to boost the candidacidal potential of neutrophils and Candida clearance (B€ ar et al., 2014) . Analyses of the intracellular expression of the IL-15 trans-presenting receptor IL-15Ra, which reflect the production of IL-15 (Mortier et al., 2008) , revealed that during C. albicans infection inflammatory Ly6C high monocytes constituted the main IL-15-producing population, both in the spleen, an organ rapidly and transiently infected by C. albicans, and in the kidney, the main Candida target organ. Since at 24 hr post infection, the spleen harbored approximately 30-fold more IL-15Ra + Ly6C high monocytes than the kidney, our findings suggest that spleen Ly6C high monocytes are the major IL-15-producing cell population during C. albicans infection. We found that resident MØs and cDCs also contributed to IL-15 production after C. albicans infection, which is in line with previous studies showing that monocytes, MØs, and cDCs (Perera et al., 2012) Production of IL-18 and IL-15 by Ly6C high inflammatory monocytes is crucial for the activation of CD8 + T cells and NK cells during Listeria infection (Soudja et al., 2012) , and Klebsiella clearance requires TNFa production by Ly6C high inflammatory monocytes, which in turn drives IL-17A production by innate lymphoid cells (Xiong et al., 2016) .
However, the relevance of IL-15 production by inflammatory Ly6C high monocytes for NK cell activation during systemic candidiasis had not been explored before, and few studies have addressed the mechanism of NK activation after C. albicans infection. IL-15 was reported to increase the in vitro microbicidal potential of human neutrophils (Musso et al., 1998) and monocytes (Vá zquez et al., 1998) in response to C. albicans. Regarding NK cell activation, IL-23 was proposed to participate in NK activation during C. albicans infection although whether this cytokine controls the activation of NK cells in the spleen was not addressed in this report.
In line with published data demonstrating that IL-15 synthesis after in vitro TLR engagement (Lucas et al., 2007) or in vivo viral infection (Colpitts et al., 2012 ) is dependent on IFNAR signaling, our data revealed that the production of IL-15 in response to C. albicans infection was suppressed in Ifnar1 À/À mice, and thus that type I IFN production was required for the production of IL-15 during systemic candidiasis. Our group has previously shown that dectin/Syk/IRF5-dependent type I IFN production is crucial for defense against C. albicans infection (del Fresno et al., 2013) . The IFNAR dependency for IL-15 production in response to C. albicans further supports the relevance of type I IFN production during fungal infections. Our results can also provide a potential explanation for the detrimental effect of type I IFN during C. albicans infection reported by the group of Kuchler and colleagues (Majer et al., 2012) , since excessive type I IFN-dependent IL-15 production might trigger an exacerbated activation of the NK cell-neutrophil axis, which could ultimately lead to neutrophil-mediated inflammatory pathology and reduced host survival. In mice, systemic candidiasis caused by intravenous Candida infection leads to the dissemination of the fungus to a number of organs including the spleen, liver and brain, which harbor low fungal loads and are as a result only transiently infected (Lionakis et al., 2011) . The kidney is the main Candida target organ, and can harbor large fungal loads paralleled by hypha formation, which can lead ultimately lead to fatal renal failure (Netea et al., 2015) . Based on the pathogenesis of invasive candidiasis, research efforts have focused on exploring the induction of anti-Candida immunological defense mechanisms in the kidney. However, at steady state the kidney immune system is limited mainly to a population of resident MØs and a low number of monocytes, DCs, and lymphocytes (Kurts et al., 2013) ; the kidney is not well prepared to mount an effective immune response during infectious processes. Our findings provide evidence supporting a pivotal collaborative function for the spleen in the establishment of anti-Candida immunity, wherein the spleen provides crucial help in order to achieve an effective immune response in the kidney during C. albicans infection. The efficient innate immune system of the spleen ensures the rapid clearance of Candida during the first hours after infection, enabling a robust spleen Ly6C high monocyte-driven IL-15 production that leads to the activation of large numbers of splenic NK cells and to the production of large amounts of GM-CSF, which are in turn required to boost the neutrophil Candida killing capacity in the kidney.
In conclusion, the present study provides strong evidence that type-I IFN dependent-IL-15 production plays a decisive function during invasive candidiasis by driving spleen NK cell activation and GM-CSF production that enables kidney neutrophils to control fungal growth. Our data therefore reinforce previous studies on the relevance of type-I IFN in antifungal immunity (McNab et al., 2015) , and on the key role fulfilled by NK cells in defense against systemic candidiasis (B€ ar et al., 2014) . However further research should be conducted to explore additional functions of type-I IFN in candidiasis, and to define the immune cell types responsible for its production after systemic C. albicans infection. Importantly, the evidence presented here on the pivotal role played by IL-15 in defense against C. albicans could set the basis for the design of potent IL-15-based immunotherapeutic strategies against fungal infections. In this regard, the development of new antifungal immunotherapies is urgently needed due to the emergence of multidrug-resistant Candida species, such as Candida auris, causing serious invasive infections (McCarthy and Walsh, 2017) , and to the relative low efficiency of antifungal chemotherapy in patients receiving immunosuppressive treatments (Kullberg and Arendrup, 2015) .
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